Ariosa Diagnostics, Inc. v. Sequenom, Inc.

809 F.3d 1282, 117 U.S.P.Q. 2d (BNA) 1153, 2015 U.S. App. LEXIS 20842, 2015 WL 9914886
Court of Appeals for the Federal Circuit·Decided December 2, 2015·No. 2014-1139, 2014-1144·Published·Cited by 7 cases

Opinions

[1284]*1284LOURIE, Circuit Judge, with whom MOORE, Circuit Judge, joins, concurs with the denial of the petition for rehearing en banc. DYK, Circuit Judge, concurs with the denial of the petition for rehearing en banc. NEWMAN, Circuit Judge, dissents from the denial of the petition for rehearing en banc.

ORDER

PER CURIAM.

A petition for rehearing en banc was filed by defendants-appellants Sequenom, Inc. and Sequenom Center for Molecular Medicine, LLC. The petition for rehearing was first referred to the panel that heard the appeal, and thereafter, to the circuit judges who are in regular active service. A response was invited by the court and filed by plaintiffs-appellees Ariosa Diagnostics, Inc. and Natera, Inc. A poll was requested, taken, and failed.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The petition for rehearing en banc is denied.

(2) The mandate of the court will issue on December 9, 2015.

Free access — add to your briefcase to read the full text and ask questions with AI

Ariosa Diagnostics, Inc. v. Sequenom, Inc., 809 F.3d 1282, 117 U.S.P.Q. 2d (BNA) 1153, 2015 U.S. App. LEXIS 20842, 2015 WL 9914886 (Fed. Cir. 2015).

809 F.3d 1282 (Ariosa Diagnostics, Inc. v. Sequenom, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

American Axle & Manufacturing v. Neapco Holdings LLC
967 F.3d 1285 (Federal Circuit, 2019)
In Re: Marco Guldenaar Holding B.V.
911 F.3d 1157 (Federal Circuit, 2018)
Interval Licensing LLC v. Aol, Inc.
896 F.3d 1335 (Federal Circuit, 2018)
Card-Monroe Corp. v. Tuftco Corp.
270 F. Supp. 3d 967 (E.D. Tennessee, 2017)